Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for sleep disturbance in adults with severe chronic pain
ISRCTN12861060Phase 3Completed
- Sponsor
- University of Aberdeen
- Start
- Jun 2019
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of melatonin in chronic pain and sleep disorder (2 arms), sponsored by University of Aberdeen. Started Jun 2019; status: completed.
02
Drugs
melatonin
03
Conditions
chronic painsleep disorder
Beyond the preview
Go deeper on ISRCTN12861060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN12861060.